U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07021066) titled 'Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors' on May 23.
Brief Summary: The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects with Advanced or Metastatic Solid Tumors.
Study Start Date: July 03
Study Type: INTERVENTIONAL
Condition:
Gastric Adenocarcinoma
Advanced Pancreatic Ductal Adenocarcinoma
Esophageal Adenocarcinoma
Mucinous Ovarian Adenocarcinoma
Other Solid Tumors
Intervention:
DRUG: BL-M05D1
BL-M05D1 will be administered on D1 every 3 weeks.
Recruitment Status: NOT_YET_RECRUITING
Sponsor...